Sanofi-Aventis Singapore Pte. Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Singapore
- Registered address
- 61 Gul Circle, Singapore, 629585, Singapore (SGP)
- Operations here
- analysisapi manufacturelabelpack
- FDA identifiers
- FEI 3003091951 · DUNS 659159243
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-06-13
- NAIDrug Quality Assurance2019-11-01
- VAIDrug Quality Assurance2017-10-13
- VAIDrug Quality Assurance2015-05-22
- NAIDrug Quality Assurance2012-03-09
- VAIDrug Quality Assurance2010-07-15
Drugs this plant is listed as making
1 distinct drugs across 31 products name this site in their FDA label.
- enoxaparin sodiumFresenius Kabi USA, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.